会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Method and Composition for Restructuring Keratin Fibers
    • 重组角蛋白纤维的方法和组成
    • US20080279803A1
    • 2008-11-13
    • US11569355
    • 2005-04-08
    • Sabine KainzUrsula HuchelOlaf LammerschopBurkhard MullerThorsten Knappe
    • Sabine KainzUrsula HuchelOlaf LammerschopBurkhard MullerThorsten Knappe
    • A61K8/84A61Q5/04
    • A61K8/64A61K8/22A61K8/23A61K8/44A61Q5/00A61Q5/004A61Q5/12
    • The invention relates to a method for restructuring keratin fibers, whereby a keratin fiber is contacted with (a) an aqueous preparation of at least one polysulfide of formula (I), wherein R represents hydroxy or the group (II), R represents hydrogen or the group (III), A is a bond or a bivalent saturated or mono- or polyunsaturated aliphatic or aromatic hydrocarbon group having 1 to 20 carbon atoms, which can be substituted by one or more halogen, hydroxy or carboxy groups and whereby the shortest bond between the carbonyl groups adjacent to group A consists of up to 12 carbon atoms, and wherein R and R are the same or different and are selected from R O— and (IV), wherein R represents hydrogen or an alkyl group having 1 to 6 carbon atoms, n is an integer of from 1 to 100, and whereby one or more carboxyl groups may be present in the form of one or more of its/their salts, and, either simultaneously or successively, a reducing agent, and then (b) with an oxidant. The invention also relates to preparations for use in the inventive methods.
    • 本发明涉及一种重组角蛋白纤维的方法,其中角蛋白纤维与(a)式(I)的至少一种多硫化物的水性制剂接触,其中R 3表示羟基或基团(II),R 4表示氢或基团(III),A是可以被一个或多个卤素,羟基或羧基取代的具有1-20个碳原子的键或二价饱和或单或多不饱和脂族或芳族烃基 并且其中与A组相邻的羰基之间的最短键由至多12个碳原子组成,并且其中R 1和R 2相同或不同并且选自R 5 O-和( IV),其中R 5表示氢或具有1至6个碳原子的烷基,n为1至100的整数,并且其中一个或多个羧基可以以其一个或多个的形式存在 /它们的盐,以及同时或依次地还原剂,然后(b)与氧化剂反应。 本发明还涉及用于本发明方法的制剂。
    • 3. 发明授权
    • Alkoxylactones, alkoxylactams and alkoxythiolactams for controlling processes based on microbial interaction
    • 用于控制基于微生物相互作用的方法的烷氧基内酯,烷氧基内酰胺和烷氧基硫醇内酰胺
    • US07825268B2
    • 2010-11-02
    • US11473795
    • 2006-06-22
    • Stefan StumpeRoland BrevesUrsula HuchelFrank JanssenAndré Hätzelt
    • Stefan StumpeRoland BrevesUrsula HuchelFrank JanssenAndré Hätzelt
    • A61K31/4015A61K31/341C07D207/26C07D307/33
    • C07D307/33A61L2/0082A61L2/16
    • Compounds of the Formula I, wherein A1 is O or NH; A2 is O or S; each of R1 and R2 is independently hydrogen, a methyl or C2-C8-saturated or mono- or doubly unsaturated, branched or linear hydrocarbon group; and R3 is a C1-C18-saturated or mono- or doubly unsaturated, branched or linear hydrocarbon group wherein, each of R1, R2 and R3 comprises a heteroatom selected from the group consisting of O and S in the chain and/or is mono- or multiply-substituted by a substituent selected from the group consisting of halogen, hydroxy, C1-C6-alkyl, trifluoromethyl, C1-C6-alkoxy, C6-C10-aryl, and C1-C6-alkyl-C6-C10-aryl are useful for controlling the interaction process between microorganisms such as in the development and/or maturation of biofilms; multicellular swarm behavior; the concerted development of antibiotic resistances; the concerted synthesis of antibiotics; the concerted synthesis of pigments; the concerted production of extracellular enzymes; or the concerted production of virulence factors.
    • 式I的化合物,其中A1是O或NH; A2为O或S; R 1和R 2各自独立地为氢,甲基或C 2 -C 8饱和或单或双不饱和,支链或直链烃基; 并且R 3是C 1 -C 18饱和或单或双不饱和,支链或直链烃基,其中R 1,R 2和R 3各自包含选自链和O中的O和S的杂原子和/或是单 或被选自卤素,羟基,C 1 -C 6 - 烷基,三氟甲基,C 1 -C 6 - 烷氧基,C 6 -C 10 - 芳基和C 1 -C 6 - 烷基-C 6 -C 10 - 芳基的取代基取代或多取代 可用于控制微生物之间的相互作用过程,例如在生物膜的开发和/或成熟中; 多细胞群体行为; 抗生素抗药性的协调发展; 协同合成抗生素; 色素的协同合成; 协同生产细胞外酶; 或协同生产的毒力因素。